CommentaryDNA Base Excision Repair Defects in Human Pathologies
- 1 October 2004
- journal article
- review article
- Published by Taylor & Francis in Free Radical Research
- Vol. 38 (10) , 1037-1054
- https://doi.org/10.1080/10715760400011445
Abstract
DNA base excision repair (BER) is the main pathway for repair of endogenous damage in human cells. It was expected that a number of degenerative diseases could derive from BER defects. On the contrary, the link between BER defects and human pathology is elusive and the literature is full of conflicting results. The fact that most studies have investigated DNA variations but not their functional consequences has probably contributed to this confusing picture. From a functional point of view, it is likely that gross BER defects are simply not compatible with life and only limited reductions can be observed. Notwithstanding those limits, the pathological consequences of partial BER defects might be widespread and significant at the population level. This starts to emerge in particular for colorectal and lung cancer.Keywords
This publication has 98 references indexed in Scilit:
- Increased expression and no mutation of the Flap endonuclease (FEN1) gene in human lung cancerOncogene, 2003
- hOGG1 exon7 polymorphism and gastric cancer in case–control studies of Japanese Brazilians and non-Japanese BraziliansCancer Letters, 2001
- Synergism between base excision repair, mediated by the DNA glycosylases Ntg1 and Ntg2, and nucleotide excision repair in the removal of oxidatively damaged DNA bases in Saccharomyces cerevisiaeMolecular Genetics and Genomics, 2001
- Going APE over ref-1Mutation Research/DNA Repair, 2000
- Functional mutation of DNA polymerase β found in human gastric cancer – inability of the base excision repair in vitroMutation Research/DNA Repair, 1999
- Alteration of hMSH2 and DNA Polymerase β Genes in Breast Carcinomas and FibroadenomasBiochemical and Biophysical Research Communications, 1999
- A parallel study of in vitro sensitivity to benzo[a]pyrene diol epoxide and bleomycin in lung carcinoma cases and controlsCancer, 1998
- Role of a BRCT domain in the interaction of DNA ligase III-α with the DNA repair protein XRCC1Current Biology, 1998
- Advances in the analysis of chromosome alterations in human lung carcinomasCancer Genetics and Cytogenetics, 1997
- DNA polymerase β gene mutations in human bladder cancerMolecular Carcinogenesis, 1996